PolypStim

Uses existing endoscopes to bioelectrically read, diagnosis and deliver customized patient specific bioelectric signals to aide in shrinking polyps, fibroids and cysts and to promote rapid healing, reduced bleeding and rapid pain relief.

What is the PolypStim Technology Platform?

PolypStim uses standard endoscopes as a carrier to deliver bioelectric signals to polyps, cysts and fibroids to accelerate their shrinkage, prevent their reoccurrence, accelerate healing and also reduce bleeding, inflammation and pain.

Computer Generated Graphic For Representation Purposes Only
Not Actual Product

The global polyps market alone is expected to reach US$ 18.3 billion by 2023, and the market is projected to grow at a CAGR of ~ 9.2 % during the forecast period 2017-2023.

WANT TO LEARN MORE OR GET INVOLVED?